⬆
✘
 
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,
⌂ /ICD-10 diagnoses /
 Share

J42 Unspecified chronic bronchitis

Add Analogs Compare
Found 10 (10) ⓘ✘Found 10 drugs (10 of these, according to Kiberis statistics) in 0 selected books (authors) ... hide
  Effect Influence Cases ⓘ ✘ Effect - how much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E) is high, but the effect (I) negative, because the patient will get worse over time.
Influence of the symptom on the outcome of the patient's treatment as a whole (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
Cases - the number of investigated treatment results for a given complaint, on the basis of which the effect and effect were calculated. These cases have already passed automatic AI verification of data quality and reliability.
  • j42 unspecified chronic bronchitis
  •  67%+23%9   Hidden. Need a subscription
    Chronical bronchitis - E 67% (I 23%, 9 cases.); Chronic bronchitis unspecified - E 67% (I 23%, 9 cases.)
  •  44%+11%3 read Silica terra
    Chronical bronchitis - E 44% (I 11%, 3 cases.); Chronic bronchitis unspecified - E 44% (I 11%, 3 cases.)
  •  42%+0%9 read Kalium carbonicum
    Chronical bronchitis - E 42% (I 0%, 9 cases.); Chronic bronchitis unspecified - E 42% (I 0%, 9 cases.)
  •  31%-6%8 read Calcarea carbonica
    Chronical bronchitis - E 31% (I -6%, 8 cases.); Chronic bronchitis unspecified - E 31% (I -6%, 8 cases.)
  •  29%-1%8 read Pulsatilla nigricans
    Chronical bronchitis - E 29% (I -1%, 8 cases.); Chronic bronchitis unspecified - E 29% (I -1%, 8 cases.)
  •  23%-15%11 read Phosphorus
    Chronical bronchitis - E 23% (I -15%, 11 cases.); Chronic bronchitis unspecified - E 23% (I -15%, 11 cases.)
  • 22%+3%12 read Sulphur
    Chronical bronchitis - E 22% (I 3%, 12 cases.); Chronic bronchitis unspecified - E 22% (I 3%, 12 cases.)

    хронический бронхит,хронический бронхит неуточненный

    • ⇒ 42% +16% 4 with «inflammation»
    • On average: 22% 3% 12 

    хронический бронхит,хронический бронхит неуточненный

    • ⇒ 42% +16% 4 with «inflammation»
    • On average: 22% 3% 12 
  • 21%-8%7 read Natrum muriaticum
    Chronical bronchitis - E 21% (I -8%, 7 cases.); Chronic bronchitis unspecified - E 21% (I -8%, 7 cases.)

    хронический бронхит,хронический бронхит неуточненный

    • On average: 21% -8% 7 
    • ⇒ 0% -35% 3 with «swelling»

    хронический бронхит,хронический бронхит неуточненный

    • On average: 21% -8% 7 
    • ⇒ 0% -35% 3 with «swelling»
  •  7%-17%3 read Kali bichromicum
    Chronical bronchitis - E 7% (I -17%, 3 cases.); Chronic bronchitis unspecified - E 7% (I -17%, 3 cases.)
  •  5%-19%3 read Nux vomica
    Chronical bronchitis - E 5% (I -19%, 3 cases.); Chronic bronchitis unspecified - E 5% (I -19%, 3 cases.)

Tree of ICD-10 diagnoses

  1. Description
  2. Related diseases
  3. Related clinical guidelines
  4. Related standards of medical care
  5. Basic medical services
  6. Clinics for treatment

Other names and synonyms

J42.
J42 Unspecified chronic bronchitis

Description

There is no detailed description, see related

Related diseases

J42 Unspecified chronic bronchitis

Related clinical guidelines

Related standards of medical care

42a96bb5c8a2acfb07fc866444b97bf1
✘Available only when using PRO account
Content moderator: Vasin A. S.


  1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
  2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
  3. Nothing in the information provided should be interpreted as a call to use these drugs.
  4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.